Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19846344rdf:typepubmed:Citationlld:pubmed
pubmed-article:19846344lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:19846344lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:19846344lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:19846344lifeskim:mentionsumls-concept:C0021403lld:lifeskim
pubmed-article:19846344lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:19846344lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:19846344lifeskim:mentionsumls-concept:C2368628lld:lifeskim
pubmed-article:19846344pubmed:issue2lld:pubmed
pubmed-article:19846344pubmed:dateCreated2010-2-4lld:pubmed
pubmed-article:19846344pubmed:abstractTextTwenty-eight patients with low-moderate, stable rheumatoid arthritis (RA), under treatment with tumor necrosis factor (TNF) alpha blockers, were immunized at least once with non-adjuvanted trivalent influenza vaccine during three consecutive influenza seasons. Antibodies toward A influenza antigens significantly increased and reached protective levels, still detectable 6 months after vaccination, both in RA patients and healthy controls. Response to B antigen instead was only observed from the second year for healthy controls and in the third year for patients. No significant difference in disease activity and anti-nuclear antibodies was observed as a consequence of vaccine administration, whereas T regulatory cells showed a significant increase 30 days after immunization in RA patients. This study confirms safety of influenza vaccine administration in RA patients treated with TNFalpha blockers. The cohort follow-up revealed the overcoming of poor B vaccine antigen immunogenicity via repeated vaccinations. Finally, protective antibody response was still observed 6 months after vaccination.lld:pubmed
pubmed-article:19846344pubmed:languageenglld:pubmed
pubmed-article:19846344pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846344pubmed:citationSubsetIMlld:pubmed
pubmed-article:19846344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846344pubmed:statusMEDLINElld:pubmed
pubmed-article:19846344pubmed:monthFeblld:pubmed
pubmed-article:19846344pubmed:issn1521-7035lld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:RossiFFlld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:DonatelliIIlld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:PodestàEElld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:FacchiniMMlld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:BiselliRRlld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:NisiniRRlld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:Di RosaRRlld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:GermannWWlld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:Di MartinoAAlld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:LaganáAAlld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:SalemiSSlld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:TabaccoFFlld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:AmodeoRRlld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:FerlitoCClld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:MilanettiFFlld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:D AmelioRRlld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:Picchianti-Di...lld:pubmed
pubmed-article:19846344pubmed:authorpubmed-author:CappellaAAlld:pubmed
pubmed-article:19846344pubmed:copyrightInfoCopyright 2009 Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:19846344pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19846344pubmed:volume134lld:pubmed
pubmed-article:19846344pubmed:ownerNLMlld:pubmed
pubmed-article:19846344pubmed:authorsCompleteYlld:pubmed
pubmed-article:19846344pubmed:pagination113-20lld:pubmed
pubmed-article:19846344pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:meshHeadingpubmed-meshheading:19846344...lld:pubmed
pubmed-article:19846344pubmed:year2010lld:pubmed
pubmed-article:19846344pubmed:articleTitleInfluenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity.lld:pubmed
pubmed-article:19846344pubmed:affiliationSapienza Università di Roma, II Facoltà di Medicina e Chirurgia, A.O. S. Andrea, Via di Grottarossa 1039, Roma 00189, Italy.lld:pubmed
pubmed-article:19846344pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19846344pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:19846344pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19846344lld:pubmed